Evidence map›Paper›PMID 35692770›Full record

ArticleFrontiers in oncology2022

Epirubicin Enhances the Anti-Cancer Effects of Radioactive

Lei Guo, Jiali Sun, Changjun Wang, Yang Wang, Ya Wang, Dong Li, Yuliang Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lei GuoDepartment of Vascular Anomalies and Interventional Radiology, Qilu Children's Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Jiali SunDepartment of Vascular Anomalies and Interventional Radiology, Qilu Children's Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Changjun WangDepartment of Interventional Radiology, Jiyang People's Hospital of Jinan, Jinan, China.
Yang WangDepartment of Interventional Medicine, The Second Hospital, Cheello College of Medicine, Shandong University, Jinan, China.
Ya WangDepartment of Vascular Anomalies and Interventional Radiology, Qilu Children's Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Dong LiDepartment of Interventional Medicine, The Second Hospital, Cheello College of Medicine, Shandong University, Jinan, China.
Yuliang LiDepartment of Interventional Medicine, The Second Hospital, Cheello College of Medicine, Shandong University, Jinan, China.
Qilu Hospital of Shandong University · CNSecond Hospital of Shandong University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application and promotion of

Indexed as

anti-cancer effectEpirubicinhepatocellular carcinomaJAK/STAT1 pathwayradioactive 125I seeds

Identifiers

PMID35692770
PMCPMC9184686
OpenAlexW4281871310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.